Immunocore appoints Pr John Bell to its Board of Directors – Talent4Boards

http://bit.ly/1udrCUE

talent4boards.com
– Talent4Boards Team
Talent4Boards – Great Talent builds Great Boards
– UK, Oxford – Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer, viral infections and autoimmune disease, today announced the appointment of Professor Sir John Bell, the Regius Professor of Medicine at Oxford University and Chairman of the Office for the Strategic Coordination of Health Research, to its Board of Directors with immediate effect.… => more
Immunocore appoints Pr John Bell to…  show all text

posted by friends:
 (4)
@NEDworks on Twitter
@NEDworks: Immunocore appoints Pr John Bell to #BoardOfDirectors ow.ly/L21tK #NonExec #biotech @Immunocore

@WholeBoardDev on Twitter
@WholeBoardDev: Immunocore appoints Pr John Bell to #BoardOfDirectors ow.ly/L21tK #NonExec #biotech @Immunocore

@excellencia_ltd on Twitter
@excellencia_ltd: Immunocore appoints Pr John Bell to #BoardOfDirectors ow.ly/L21tK #NonExec #biotech @Immunocore

@talent4boards on Twitter
@talent4boards: Immunocore appoints Pr John Bell to #BoardOfDirectors ow.ly/L21tK #NonExec #biotech @Immunocore

posted by followers of the list:
 (0)

Vía All News on ‘The Twitter Times: Muzaffar69/corpgov’ http://bit.ly/19FO3Il

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: